A narrative expert review examining regulatory frameworks, scientific challenges, and strategic recommendations for pediatric oncology drug development—informative but not empirical evidence of a clinical intervention's efficacy.
A narrative review synthesizing case reports and pharmacovigilance signals to propose mechanisms linking ICI use to AA amyloidosis; the source explicitly states mechanisms are hypotheses rather than confirmed pathways and evidence remains scarce with causality unestablished.